STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression.

@article{Kohsaka2012STAT3IO,
  title={STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression.},
  author={Shinji Kohsaka and Lei Wang and Kazuhiro Yachi and Roshan Mahabir and Takuhito Narita and Tamio Itoh and Mishie Ann Tanino and Taichi Kimura and Hiroshi Nishihara and Shinya Tanaka},
  journal={Molecular cancer therapeutics},
  year={2012},
  volume={11 6},
  pages={1289-99}
}
Glioblastoma multiforme (GBM) is one of the most aggressive human tumors with a poor prognosis. Current standard treatment includes chemotherapy with the DNA-alkylating agent temozolomide concomitant with surgical resection and/or irradiation. However, a number of cases are resistant to temozolomide-induced DNA damage due to elevated expression of the DNA repair enzyme O(6)-methylguanine-DNA methyltransferase (MGMT). Here, we show that upregulation of both MGMT and STAT3 was accompanied with… CONTINUE READING
51 Citations
57 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 51 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 57 references

American Association for Cancer Research. mct.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited

  • MS Carro, WK Lim, MJ Alvarez, RJ Bollo, X Zhao, EY Snyder
  • The on June
  • 2012
Highly Influential
3 Excerpts

STAT 3 mediates resistance to MEK inhibitor through microRNA miR17

  • B Dai, J Meng, M Peyton, L Girard, WG Bornmann, L Ji
  • Cancer Res
  • 2011

Caffeine confers radiosensitization of PTENde fi cient malignant glioma cells by enhancing ionizing radiation - induced G 1 arrest and negatively regulating Akt phosphorylation

  • B Sinn, G Tallen, G Schroeder, B Grassl, J Schulze, V Budach
  • MolCancer Ther
  • 2010

Similar Papers

Loading similar papers…